PAP and Paracetamol Market Forecast, Trend Analysis and Competition Tracking - Global Industry Insights 2015 to 2031

Global PAP and Paracetamol Market Revenue Outlook:

The global PAP and Paracetamol Market is valued at US$ 1,617.6 Mn in 2021 and is projected to register а САGR of 2.5% by 2031.

Nonetheless, various industry players in the global PAP and Paracetamol Market are now increasing their focus on establishing successful collaborations, acquisitions, and joint venture activities to enhance their respective customer bases.

These players are also growing their supply capabilities to meet customer requirements on a local and global scale. This factor, paired with promising industrialization prospects in developing economies of the Asia-Pacific region, such as China, India, Taiwan, Indonesia, etc., are expected to create massive business opportunities for key players over the forecast period.

Paracetamol & p-Aminophenol (PAP) is widely used as an analgesics drug that acts as a pain reliever and a fever reducer. Additionally, it is used to treat many conditions such as headache, muscle aches, arthritis, colds, toothaches, backache, and fevers.

It relieves pain in mild arthritis but does not affect the underlying inflammation and swelling of the joint. Paracetamol & p-Aminophenol (PAP) are widely used Active Pharmaceutical Ingredients (API), which are commonly referred to as "Drug substance" or "Bulk pharmaceutical chemical". The active ingredient is the substance that is biologically active in a pharmaceutical drug.

Active pharmaceutical ingredients of good quality are core to manufacturing effective and safe essential drugs. Initially, only a few large manufacturers of finished pharmaceutical products had their active pharmaceutical ingredients manufacturing plants. Many manufacturers used to buy the active pharmaceutical ingredients from the exposed market.

Some drugs may contain more than one active pharmaceutical ingredient. All medicine includes two main components, active pharmaceutical ingredient (API), which is the main component that shows the therapeutic effect, and excipients which helps in the delivery of medication.

Excipients are chemically inactive substances such as mineral oil and act as vehicles for conveying active ingredients to the target site. Active pharmaceutical ingredients (API) play an important role in diseases prevention and treatment. For any disease, treatment is chosen based on the active ingredient used in it.

Paracetamol Brand Names In Countries

To learn more about this report, request for Sample Report

Leading Paracetamol Manufacturers Production Capacity (MT), 2020

To learn more about this report, request for Sample Report

Factors Having Positive Effect On The Market

The rising prevalence of headaches, flu, and the increasing demand for pain management drugs fuel the demand. PAP and Paracetamol are widely used to treat mild to moderate pains, including headaches, menstrual periods, toothaches, backaches, osteoarthritis, or cold/flu aches and pains. Furthermore, it is an effective antipyretic used to reduce fever. The growing burden of the indicative conditions and OTC use of the products drive the market's growth.

With an increase in the number of FDA approvals for new molecular entities, large-scale manufacturers are now focusing on active pharmaceutical ingredient production; most of the major generic drug manufacturing companies have their API manufacturing facility, a trend witnessed in the global PAP and Paracetamol market.

Restraints for Growth of the Global PAP and Paracetamol Market

Strict rules and regulations set by various drug administrative bodies, inappropriate drug cost control policies across multiple nations are the restraints that hampers the growth of the PAP and Paracetamol market

Regional Analysis for PAP and Paracetamol Market

Currently, the market in Asia Pacific regions dominates the active pharmaceutical ingredient markets in terms of revenue. The region is also projected to have the fastest-growing market, and the increasing acceptance and penetration are enhancing the biopharmaceuticals drug market in both developed and developing economies.

India produces approximately 5,600 metric tons of Paracetamol every month. The domestic requirement is around 200 metric tons, and the rest of Paracetamol is exported to countries such as Italy, Germany, the UK, the US, Spain, and Canada. This is expected to fuel the revenue growth of the Asia-Pacific PAP and Paracetamol Market.

Leading Paracetamol Players Market Share (%), 2021

Competitive Landscape

The PAP and Paracetamol Market landscape appears highly consolidated, with a significant chunk dominated by the players.

• Granules India Ltd
• Sri Krishna Pharmaceuticals
• Gujarat Farmson Pharmaceuticals
• Meghmani LLP
• Bharat Chemicals
• Para Products Pvt Ltd
• Farmson Pharmaceutical Gujarat Pvt. Ltd.
• Anqiu Lu'an Pharmaceutical Co., Ltd.
• Hebei Jiheng Pharmaceutical Co., Ltd.
• ABHILASH CHEMICALS & PHARMACEUTICALS PVT. LTD.
• Other Key Players

Report Scope

• Forecast Period: 2022-2031
• Actual Year: 2021
• Historical Data Available for: 2015-2020

Key Regions Covered

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Segments Covered for Global PAP and Paracetamol Market

Global PAP and Paracetamol Market Segmented by Form

• Powder
• Granules

Global PAP and Paracetamol Market Segmented by Application

• Tablet Drug
• Granules Drug
• Oral Solution

To learn more about this report, request for Sample Report